Physician profile
Melissa A Appleton
NPI 1144287053
$1,129.62
in general payments reported to CMS, 2019-2025
16 companies · $80.97 in 2025
The $80.97 reported for 2025 was less than what a typical Internal Medicine provider received nationally (typical 2025 total: $156).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $55.95 · 2020: $54.70 · 2021: $169 · 2022: $305 · 2023: $307 · 2024: $157 · 2025: $80.97.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $545.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $544.93 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Janssen Pharmaceuticals, INC | $178.83 | 2020-2023 | Xarelto |
| Novartis Pharmaceuticals Corporation | $163.20 | 2021-2024 | |
| Salix Pharmaceuticals, A Division of Bausch Health US, LLC | $162.43 | 2019-2024 | Xifaxan |
| La Jolla Pharmaceutical Company | $153.24 | 2021-2023 | Xerava |
| Abbvie INC. | $97.94 | 2023-2025 | Dalvance, Teflaro |
| Pfizer INC. | $90.92 | 2022-2024 | |
| Boston Scientific Corporation | $39.43 | 2023-2024 | Watchman Flx |
| Novo Nordisk INC | $38.47 | 2022-2023 | |
| E.R. Squibb & Sons, L.L.C. | $38.11 | 2021-2022 | |
| Merck Sharp & Dohme LLC | $36.95 | 2022-2023 | Dificid, Zerbaxa |
| Stryker Corporation | $28.55 | 2025 | Flowtriever Catheter, S, Ct Thrombectomy System Kit |
| Tetraphase Pharmaceuticals, INC. | $24.43 | 2020 | |
| Boehringer Ingelheim Pharmaceuticals, INC. | $23.73 | 2019 | |
| Paratek Pharmaceuticals, INC. | $22.96 | 2025 | Nuzyra |
| Gilead Sciences, INC. | $15.41 | 2021 |
Show all 16 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Irhythm Technologies, INC. | $15.02 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Melissa Appleton listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.